¿Influye la microbiota en el riesgo de obesidad infantil? by Sanches Oliveira, Rita Cristina et al.
Rev Esp Nutr Hum Diet. 2018; 22(2).   
doi: 10.14306/renhyd.22.2.389 [ahead of print]  
 
Freely available online - OPEN ACCESS 
 
La Revista Española de Nutrición Humana y Dietética se esfuerza por m antener a un sistem a de publicación continua, de 
m odo que los artículos se publican antes de su form ato final (antes de que el núm ero al que pertenecen se haya cerrado 
y/o publicado). De este m odo, intentam os poner los artículos a disposición de los lectores/usuarios lo  antes posible.  
The Spanish Journal of Hum an Nutrition and Dietetics strives to m aintain a continuous publication system , so that the 
articles are published before its final form at (before the number to which they belong is closed and/or published). In  this 
way, we try to put the articles available to readers/users as soon as possible. 
 
Esta obra está bajo una licencia de Creative Com m ons Reconocim iento -NoCom ercial-Com partirIgual 4.0 Internaciona l 
  
Revista Española de Nutrición Humana y Dietética 
Spanish Journal of Human Nutrition and Dietetics  
 
ARTÍCULO DE REVISIÓN  versión post-print  
Esta es la versión aceptada. El artículo puede recibir modificaciones de estilo y de formato.  
 
Does microbiota influence the risk of childhood obesity? 
¿Influye la microbiota en el riesgo de obesidad infantil? 
 
 
Rita Cristina Sanches Oliveiraa*, Pedro Miguel Barata de Silva Coelhoa, María del Carmen 
Lozano Estevanb. 
a Faculdade de Ciências da Saúde, Universidade Fernando Pessoa. Porto, Portugal. 
b Departamento de Farmacia, Universidad Alfonso X el Sabio. Madrid, España. 
* ritao@ufp.edu.pt  
  
Recibido: 31/03/2017; Aceptado: 10/12/2017; Publicado: 21/05/2018 
CITA: Oliveira R, Coelho PMBS, Lozano Estevan MC. Does microbiota influence the risk of 
childhood obesity?. Rev Esp Nutr Hum Diet. 2017; 22(2). doi: 10.14306/renhyd.22.2.389 [ahead of 
print] 
 
Rev Esp Nutr Hum Diet. 2018; 22(2).  Freely available online - OPEN ACCESS 
doi: 10.14306/renhyd.22.2.389 [ahead of print] 
2 
Esta obra está bajo una licencia de Creative Com m ons Reconocim iento -NoCom ercial-Com partirIgual 4.0 Internaciona l 
 
ABSTRACT 
Childhood obesity is associated to incremented risk of developing diseases such as diabetes, 
cardiovascular diseases, or cancer, later in life. Several factors affect infant weight gain such as 
genetics, maternal lifestyle, and other environmental factors. Perinatal period is considered to be 
the most important one to when defining metabolic programming of the future adult. Several 
previous researches have discussed the role that gut microbiota might play on obesity risk and 
its development between 3-5 years old. Again, perinatal period is crucial to define quantity and 
diversity of a healthy intestinal microbiota. Maternal diet/BMI, delivery mode, antibiotic exposure 
and breastfeeding are some of the processes that will determine a favorable gut microbiota. 
Functions of gut microbiota, mostly by producing short-chain fatty acids as metabolites, include 
regulation of metabolism and immune system of the host, which may be compromised in case of 
dysbiosis. This review pretends to evaluate the state of the art concerning infant obesity and the 
role of gut microbiota. Despite the large amount of scientific publications, there is still much work 
to do regarding the clarification of mechanisms and the possible therapy for childhood obesity.  
Keywords: Obesity; Gastrointestinal Microbiome; Pediatric Obesity; Breast Feeding; Dysbiosis.  
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RESUMEN 
La obesidad infantil se asocia con el incremento del riesgo de desarrollar futuras enfermedades 
como la diabetes, las enfermedades cardiovasculares o el cáncer. Varios factores afectan la 
ganancia de peso infantil, como la genética, el estilo de vida materno y otros factores 
ambientales. El período perinatal es considerado como el más importante a la hora de definir la 
programación metabólica del futuro adulto. Varias investigaciones previas han discutido el rol 
que podría tener la microbiota intestinal en el riesgo de obesidad y su desarrollo entre los 3 y 5 
años. Una vez más, el período perinatal es crucial para definir la cantidad y la diversidad de una 
microbiota intestinal saludable. La dieta materna, el tipo de parto, la exposición a los antibióticos 
y la lactancia materna son algunos de los procesos que determinarán una microbiota intestinal 
favorable. Las funciones de la microbiota intestinal, principalmente mediante la producción de 
ácidos grasos de cadena corta como metabolitos, incluyen la regulación del metabolismo y el 
sistema inmunológico del huésped, que pueden estar comprometidos en caso de disbiosis. Esta 
revisión pretende evaluar el estado del arte en relación con la obesidad infantil y el papel de la 
microbiota intestinal. A pesar de la gran cantidad de publicaciones científicas, todavía hace falta 
aclarar los mecanismos y la posible terapia para la obesidad infantil.  
Palabras clave: Obesidad; Microbioma Gastrointestinal; Obesidad Pediátrica; Lactancia Materna; 
Disbiosis. 
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INTRODUCTION 
World Health Organization (WHO) has stated the following facts about obesity1: 
 Obesity is defined as an abnormal or excessive fat accumulation that may impair health 
and results from an energy imbalance between calories consumed and calories expended;  
 Overweight and obesity are linked to more deaths worldwide than underweight; 
  Globally there are more people who are obese than underweight  this occurs in every 
region except parts of sub-Saharan Africa and Asia; 
 In 2014, more than 1.9 billion adults, 18 years and older, were overweight and of these 
over 600 million were obese; 
 In 2014, 41 million children under the age of 5 were overweight or obese. 
Obesity is considered an epidemic disease escalating in all population groups in developed and 
developing countries. The prevalence of overweight and obesity combined has risen by 27.5% for 
adults and 47.1% for children between 1980 and 20132. Some explanations for the 
epidemiological obesity where proposed including increases in energy intake, changes in the 
composition of diet, reduced physical activity, and changes in the gut microbiome2. Excessive 
weight gain in infancy is associated with persistence of high weight status and later obesity, 
resulting in an incremented risk to develop diseases such as diabetes, cardiovascular diseases, 
musculoskeletal disorders, cancer and mortality1,3. Obese children can also present breath 
difficulties, increased risk of fractures, hypertension, insulin resistance and psychological 
disorders1. Infant obesity and severe obesity has increased over the recent decades and despite 
this increase appears to slow down, the prevalence of child obesity is still too high worldwide4. 
Woo Baidal et al. concluded in their systematic review from prospective studies with scientific 
evidence, that the main factors affecting childhood obesity are higher maternal pre-pregnancy 
body mass index (BMI), prenatal tobacco exposure, maternal excess gestational weight gain, high 
infant birth weight, and accelerated infant weight gain. They also found that the critical period is 
from conception through 2nd years old5. 
With different degrees of evidence, there are some important issues that appear to determine the 
risk of obesity in childhood: genetics6-8 and epigenetics3,9; in uterus environment and maternal 
health4,10; growth acceleration in the 1st six months10,11; metabolic programming of endocrine 
response11-14; breastfeeding and infant formulas15-24; introduction of solid food25; and intestinal 
microbiota12. Intestinal microbiota is defined early in life and recent studies suggested its relation 
to later obesity risk and other diseases. The intestinal microbiota influences energy balance 
producing short-chain fatty acids (SCFA) from polysaccharides digestion. Different bacteria have 
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diverse modes of influencing absorption and storage of energy and several factors define 
colonization in infants12. 
To prevent childhood obesity, it is imperative to work on these factors, particularly those who can 
be affected by maternal or caregiver behavior: maternal BMI, breastfeeding human milk (breast 
vs bottle), formula composition, feeding practices for introduction of solids, early nutritional 
education with impact on metabolism routes, taste preferences and food choices in the future26.  
The intestinal microbiota is a new insight that has emerged in recent investigations as a 
modulating factor of obesity. Knowing its possible role as a risk factor in childhood obesity is the 
main goal of this review. 
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MECHANISMS OF ACTION OF THE INTESTINAL MICROBIOTA 
The impact of microbiota metabolism in human body has been discovered as more studies have 
been published linking intestinal microbiota and some developed pathologies, in germ-free mice 
and in humans. Alterations in microbiota populations are related to the development of 
inflammatory and metabolic diseases like inflammatory bowel disease, obesity, type 2 diabetes, 
atherosclerosis, allergy, and cancer27,28. 
Gut microbiota ferment complex polysaccharides and residual proteins that cannot be digested 
by human enzymes to SCFA, branched-chain fatty acids, gases, and other metabolites. Acetate 
(C2), propionate (C3) and butyrate (C4) are the main products with impact in health. These 
compounds are energy source for colonic epithelium (butyrate) and peripheral tissues (acetate, 
propionate). The composition of microbiota and the diet carbohydrates determine the amount 
and proportion of SCFA produced29. SCFA play a direct role on epithelial gut cells providing 
energy and promoting cell proliferation and differentiation. SCFA deficiency originates an energy 
deficit state that activates autophagy with impact in the integrity of intestinal barrier 27. SCFA 
receptors named G-protein coupled receptors (GPCR) are also present in peripheral tissues (white 
adipose tissue, skeletal muscle, and liver), acting as signaling molecules with impact in 
metabolism regulation (fatty acid oxidation, increasing leptin) and immune functions (reduction 
of pro-inflammatory cytokines and macrophage activation)30,31. 
Besides the production of SCFA, gut microbiota mediates other metabolism functions: bile acid 
conjugation to secondary bile acids acting as signaling molecules to regulate metabolism and 
immune cells32; vitamin (complex B and K), amino acids and lipid synthesis, digestion or 
absorption27,33,34; pathogens barrier27; immune function by gut associated lymphoid tissue (GALT) 
that represents about 70% of the total immune system35; neuroendocrine regulation by the gut-
brain axis, where dysbalanced axis is associated to gastrointestinal diseases (chronic gut 
inflammations, pain, and metabolic disorders) as well as mood, behavior, stress disorders and 
satiety mechanism36,37. 
The intestinal microbiota is composed by numerous microorganisms mostly from Bacteria 
kingdom. About 90% belong to the phyla Firmicutes and Bacteroidetes and the most abundant 
genera are Bacteroides, Faecalibacterium and Bifidobacterium which proportions vary between 
individuals. At species level, there is a great variety which can originate a unique profile for each 
host38. 
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Environmental variations influence intestinal microbiota composition such as pH, oxygen and 
nutrient availability. The bacterial concentration is higher in the lower portion of the 
gastrointestinal tract dominating the anaerobes (Figure 1). 
Rev Esp Nutr Hum Diet. 2018; 22(2).  Freely available online - OPEN ACCESS 
doi: 10.14306/renhyd.22.2.389 [ahead of print] 
8 
Esta obra está bajo una licencia de Creative Com m ons Reconocim iento -NoCom ercial-Com partirIgual 4.0 Internaciona l 
 
Figure 1. Gut microbiota composition (Adapted from Gotteland39 and Verdu et al.40). 
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The composition of gut microbiota is defined at birth and evolves until about 3 years old, then it 
remains constant during lifetime and a few factors can temporarily change it such as antibiotics 
and diet39,41. A human study found that in twins, the similarity of microbiota is within the same 
family members and not only in monozygotic twins. This fact indicates that environmental 
exposure has more impact than genotype in microbiota development42. Diet rich on non-
digestible carbohydrates provide substrate to fermentation by gut bacteria. Limited amounts of 
fat and proteins are necessary to maintain a healthy gut metabolism. High fat and protein diets 
significantly reduced SCFA and alter intestinal bacteria composition43,44. The supplementation 
with prebiotics promote the growth of specific gut microbiota species and the use of probiotics 
has benefits in host health, but the impact on large-term gut microbiota remains to be proven45. 
 
OBESITY AND GUT MICROBIOTA 
Backhed et al.46 inoculated germ-free mice with normal gut microbial cells from conventionally 
raised mice, which resulted in a 60% increase in body fat and insulin resistance, even with a 27% 
reduction in food intake. They also found that bacterial colonization increased the storage of 
triglycerides in the adipocytes of the inoculated mice46. Ridaura et al.47 also performed a study in 
which germ-free mice were colonized by fecal microbiota of twins discordant for obesity or by 
cultured collection of lean or obese animals. Fecal cultured or uncultured feces of obese animals 
originate significantly higher increase in body mass and adiposity than those of lean animals, 
whereas transplanted microbiota of lean animals was correlated to higher quantity of SCFA 
(butyrate and propionate). When the animals were cohoused (obese and lean) the obese animals 
stopped their body weight gain modifying also their microbiota profile like lean animals 
(increasing Bacteroides). The study was also conducted under 2 types of diet (low saturated fat 
and high saturated fat). The bacterial colonization and phenotype change only occur in low 
saturated fat diet revealing a diet-dependent mechanism between diet and microbiota47. 
Recently, increasingly studies embody the evidence of intestinal microbiota intervention in 
obesity. Intestinal dysbiosis implies an alteration in quality and quantity of intestinal commensal 
bacteria which means altered fermentation products (mainly SCFA), and occurs in obese people. 
In obesity, gut microbiota is known to be altered by a decreased ratio of Bacteroidetes to 
Firmicutes, with increased capacity to harvest energy from diet48,49. It is also known that long-
term diet habits influence composition of gut microbiota. Intestinal bacteria react to daily dietary 
fat and carbohydrates and change its metabolic pattern but the extent, mechanisms and 
consequences of a dietary shift are still unknown29. 
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The main mechanisms influenced by SCFA regulation in peripheral tissues are well developed in 
several studies29-31: energy harvesting50,51, substrate metabolism52, energy expenditure53,54, 
anorectic hormone production and appetite regulation55-58. These mechanisms may 
counterbalance the extra energy source that SCFA intestinal production represent in obesity as 
well as the establishment of the low-grade inflammatory state characteristic of obese persons27. 
All these effects were observed in vitro or in animals, lacking evidence in humans, and so, those 
properties should be seen with caution.  
 
FACTORS AFFECTING INTESTINAL COLONIZATION IN CHILDREN 
The intestinal microbiota colonization occurs at birth, or before in uterus according to some 
authors, and it is the perinatal period the most important one to define gut microbiota in later 
ages.  
Early life environment factors involved are59: a) host genetics that controls gut microbiota 
diversity but, animal studies revealed that changes in diet population may alter gut microbiota 
despite host genetics60,61; b) in uterus colonization were recent studies revealed a uterine 
microbiota in healthy pregnant women62,63; c) maternal lifestyle includind diet during pregnacy64, 
overweight or excessive weight gain65, and stress66,67 modulating gut microbiota, immune system 
and milk composition68; d) birth delivery mode determine maternal transfer of vaginal, colonic 
and skin microbiota, colonizing the neonate specially with Lactobacillus and Prevotella 69-71; e) 
breastfeeding versus formula with a major impact on early microbiota composition and function, 
when compared to introduction of solid food or even the birth mode70 and were milk bacteria 
72-75; f) solid food which increases 
diversity and promotes the growth of Bacteroides and Clostridium butyrate producers and may 
be a major determinant for gut microbiota development76,77; g) antibiotics exposure that rapidly 
alters gut microbiota with short-term and long-term influences78,79; h) hygene level that also 
determines the microbial exposure and may influence the early development and diversity of gut 
microbiota80-82; i) prebiotics and probiotics administration to pregnant women and neonates have 
shown a modulation effect of child microbiota83-87. At 3 to 5 years old the gut microbiota 
composition is similar to adults and remains more or less stable. Changes may occur because of 
bacterial infections, surgeries, diet40,62, lifestyle88, and geographical area89. 
Continued research regarding the factors that can influence the development of human gut 
microbiota will enlighten the mechanism to achieve  
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IMPACT OF GUT MICROBIOTA ON DEVELOPMENT OF CHILD OBESITY 
Research in animal models have linked gut microbiota to obesity and is contributing to elucidate 
its mechanisms of interaction. However, there are not many studies in infants and several 
demand attention to their confounding factors undermining some results.  
In Table 1 are summarized the studies in infant obesity related to gut microbiota.  
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Table 1. Studies on infant obesity and gut microbiome. 
Type of study N. of 
individuals 
Ages 
(years) 
Results (in obese individuals compared to 
lean) 
Ref. 
Case-study 20 4-5 -  
-  
-  Lactobacillus, Bifidobacterium and 
Bacteroides fragilis 
90 
Case-study 53 6-16 - detes ratio 
- Lactobacillus spp. 
91 
Case-study 84 N.a. - B. fragilis and Lactobacillus 
-  
92 
Case-study 15 8-14 - No differences in gut microbiota 
composition 
-  
93 
Prospective 
study 
30 Followed 
until 10 
-  
-   
94 
Prospective 
study 
138 Followed 
until 3 
- B. fragilis 
between 3 weeks and 1 year  
95 
Prospective 
study 
909 Followed 
until 3 
- B. fragilis 96 
Prospective 
study 
246 Followed 
until 2 
- Bacteroides spp. 
- Staphylococcus spp. 
97 
Follow-up 
interventional 
study (perinatal 
1x1010 cfu of L. 
rhamnosus GG, 
ATCC 53103 
against placebo) 
113 Followed 
until 10 
- Correlation found between perinatal gut 
microbiota modulation and early obesity 
until 48 months 
98 
randomized 
controlled trial 
(symbiotic 
against placebo 
for 8 weeks) 
70 6-18 - significant decrease of tumor necrosis-  
and interleukin-6, and significant increase 
in adiponectin; 
- No differences in C-reactive protein 
99 
Randomized 
controlled trial 
(prebiotic 
against placebo) 
38 7-12 - normalized weight gain, reduced whole 
body and trunk body fat, modified primary 
fecal bile acids, and selectively altered gut 
microbiota 
100 
Open-labelled 
self-controlled 
nutritional 
intervention for 
30 days 
38 3-16 - both obese groups share the same 
dysbiosis  
- gut microbiota modulation within 30 
days of non-digestible carbohydrates diet 
- significant decrease of inflammatory 
markers 
101 
: maintenance; N.a.: non-available. 
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Observational studies reveal differences between gut microbiota of obese and lean children. 
Karlsson et al.90 studied 20 overweight or obese children and 20 normal range children with ages 
between 4-5 years old. After analyzing their intestinal microbiota they found significant 
differences in abundance but only a tendency in their diversity. The abundance of 
Enterobacteriaceae was significantly higher in the obese or overweight children, whereas a 
significantly lower of Desulfovibrio and Akkermansia muciniphila-like bacteria. No significant 
differences were found in content of Lactobacillus, Bifidobacterium or the B. fragilis group90. In 
another study comparing children between 6 and 16 years old the authors found elevated 
Firmicutes-to-Bacteroidetes ratio in obese children compared with lean ones. Additionally, low 
relative proportions of B. vulgatus and high levels of Lactobacillus spp. were observed in the obese 
children91. Gut microbiota of 30 obese, 24 overweight and 30 lean children were verified, and the 
authors found a positive correlation between BMI and high levels of B. fragilis group and 
Lactobacillus spp. while a negative correlation was found for Bifidobacterium spp.92. Obese (n=15) 
and normal weight (n=15) children aged between 8 and 14 years old were studied for their gut 
microbiota showing no significant quantitative differences in gut microbiota. However, higher 
concentrations of butyrate and propionate were found in obese versus normal weight children. 
Lower concentrations of intermediate metabolites detected in obese children, may suggest 
higher metabolic activity by obese gut microbiota leading to future dysbiosis 93. 
In a prospective study, Luoto et al.94 correlated the post-natal diet (maternal colostrum 
adiponectin concentration) and gut microbiota (at the age of 3 months) to subsequently normal 
weight (n=15) versus overweight (n=15) 10 years old children. Sex, gestational age, BMI at birth, 
mode of delivery, probiotic intervention, and duration of breast-feeding were similar in both 
groups. Colostrum adiponectin concentrations were significantly higher in mothers whose 
children were normal weight as well as the Bifidobacterium levels94. In a similar study design, 138 
infants were studied for their gut microbiota at 3, 26 and 52 weeks of age and related to their 
BMI at 1 and 3 years old. A low Staphylococcus and a high B. fragilis concentration, was associated 
with a higher BMI during the first three years of life95. The same correlation was found between B. 
fragilis group and a higher BMI when fecal samples of 909 one-month-old infants were analyzed 
and BMI were evaluated between 1 and 10 years old96. 
An interesting prospective study tried to stablish a timeline between early gut microbiota 
patterns and infant growth. Collection of fecal samples were made at postpartum day 4 (mother 
sample) and their infants at 4, 10, 30, and 120 days old, totalizing 246 children after the study of 
inclusion process was concluded. Possible study confounders such as antibiotics use (after day 4 
of life), sex, having received milk substitutes, maternal smoking, and parity were analysed and 
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removed. The aim of this work was the detection of specific gut microbiota groups that were 
significantly associated with infant growth trajectory. The samples showed 16 gut ecosystem 
developing patterns that were detected over time and some results were: detection of Bacteroides 
spp. at day 30 was significantly associated with reducing growth in males when compared to 
non-detection; detection of Staphylococcus spp. at day 4 was associated with expected growth in 
females and males; Escherichia coli detection from day 4 through to 30 was associated with 
expected growth in males. These results may be an insight to stablish a correlation between 
changes in gut microbiota development and consequent risk of obesity. This work also developed 
a novel approach to provide a potential time-dependent exposure window by observational data 
otherwise only occurred by experimental data97. 
Nadal et al.102 and Santacruz et al.103 found gut microbiota changes in obese adolescents when 
they altered their lifestyle, mainly diet and exercise, suggesting interactions between diet, gut 
microbiota and host metabolism and immunity in obesity. 
To better stablish a timeline between early gut microbiota and its impact in developing obesity 
later in life, more experimental studies need to be done. Very few can be found since ethical 
issues limit their elaboration. Luoto et al.98 performed an interventional study where 159 
pregnant women were randomized and double-blinded to receive probiotics (1x1010 CFU of L. 
rhamnosus GG, ATCC 53103) or placebo 4 weeks before delivery and extended until 6 months 
after. 113 children were enrolled in the study and their anthropometric measures were taken at 
3, 6, 12 and 24 months and at 4, 7 and 10 years. The results showed that the perinatal probiotic 
intervention appeared to moderate the initial phase of excessive weight gain (until 24-48 
months), especially among children who later became overweight, but not the second phase of 
excessive weight gain (after 4 years old). Early gut microbiota modulation appears to influence 
only infant growth in the first years of life98. 
A symbiotic (Protexin® 2.0 × 108 CFU/day of L. casei, L. rhamnosus, Streptococcus thermophilus, B. 
breve, L. acidophilus, B. longum, L. delbrueckii subsp. bulgaricus, and fructo-oligosaccharides, vitamin 
E, vitamin A, and vitamin C) was tested against placebo in a group of obese children of 6-18 years 
old in a 8 week randomized controlled trial in order to study its impact in obesity inflammatory 
markers. The symbiotic group had significant decrease in values of tumor necrosis -  and 
interleukin-6, with significant increase in adiponectin. No differences were found in C-reactive 
protein. The results were depending on weight reduction. Considering the duration of the 
intervention, symbiotic supplementation may positively influence inflammation markers99.  
In a randomized controlled trial18, obese children aged between 7 and 12 years were randomly 
included to receive a prebiotic oligofructose-enriched inulin (n=20) or a placebo for 16 weeks. No 
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significant differences were found in BMI of prebiotic group while BMI significantly increased in 
the placebo group. Percent of total body fat was significantly lowered with prebiotic compared 
with placebo showing differences in body distribution. Lean mass had a significant increase in 
both groups. It was also observed a decrease tendency in inflammatory markers in prebiotic 
group. In respect to gut microbiota modulation it was observed an increase of Bifidobacterium spp. 
in the prebiotic group. The prebiotic administration normalized weight gain, reduced whole body 
and trunk body fat, modified primary fecal bile acids (microbiota metabolites), and selectively 
altered gut microbiota100. 
Zhang et al.101 performed a nutritional intervention in 38 hospitalized children (3-16 years old) 
suffering from genetic obesity (n=17) or common obesity (n=21). After a diet rich in fermentable 
non-digestible carbohydrates (whole grains, vegetable, fruits, nuts, traditional Chinese medicinal 
food plants and prebiotics) for 30 days a significant weight loss and changes of the gut 
microbiota were observed together with a reduction of metabolic deterioration and inflammation 
markers (C-reactive protein, serum amyloid A protein, -acid glycoprotein and white blood cell 
count). The levels of adiponectin increased and leptin decreased. Lipopolysaccharide binding 
protein, a marker for bacterial antigen load in the blood also decreased. The study revealed that 
both groups of obese children shared the same pattern of dysbiosis and in both it was observed 
gut microbiota modulation after the intervention. The authors also performed an in vivo essay by 
faecal transplantation to germ-free wild-type C57BL/6J mice. Those who received pre-
intervention samples developed higher fat mass and presented high inflammatory markers and 
those who received post-intervention samples remained with the normal weight. The significant 
change on clinical parameters suggests overall structural changes at individual microbiome level. 
They also proved that long-term gut microbiota modulation by diet can be done101. 
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DISCUSSION 
Results from literature are often inconsistent as many confounders exist, namely the fact that 
different microbe identification techniques are used and the intra-individual and genotype 
differences that naturally occur. Besides in vivo animal essays, human clinical trial results are 
controversial and scarce in infant population. 
Until know it is not clear enough the correlation between gut microbiota and obesity but some 
statements can be summarized: gut microbiota is developed in early life and several factors 
contribute to its composition; gut microbiota from obese individuals differ from healthy ones, it is 
also apparent that Bacteroides spp. seem to play and important role in regulating childhood 
microbiota as well as lactobacilli, bifidobacteria, staphylococci, and a low Bacteroides/Firmicutes 
ratio, which can influence the development of overweight later in life. 
Scientists are increasingly agreeing that dysbiosis can be one of the causes of obesity and that 
diet and prebiotic/probiotic interventions can qualitatively change gut microbiota during a period 
of time that is yet unknown. It is also well accepted that shifts in microbiota may result in 
healthier clinical parameters for obese individuals. Nevertheless, despite the intense research 
seen in the recent years, there is still much work to do either in animal models to elucidate the 
molecular mechanisms in which the gut microbiota controls weight gain, in identifying specific 
microbe species for shaping body composition or in laboratory analysis to standardize microbe 
identification and even in well-
measures are effective to modulate a healthy gut microbiota development. 
Several recent reviews conclude the positive role of gut microbiota modulation in adult obesity 
treatment104-106. However, there are no sufficient data to state that child dysbiosis increase the 
risk of obesity later in life besides a few studies reported some discordant changes in gut 
microbiota of obese children. A timeline establishment between early gut microbiota and obesity 
was attempted by Richard A. et al.97 but the study was very limited in time. 
Even if more studies are still needing to clearly claim that gut microbiota modulation will play an 
important role in the treatment of obesity, earlier interventional trials in obese children open 
promising doors in that direction. 
It is already known that pregnancy and perinatal factors (maternal health and lifestyle, birth 
mode, breastfeeding) are fundamental to the development of infant gut microbiota. Infant 
dysbiosis may be transmitted and responsible for obesity programming. Primary prevention 
strategies may include modeling maternal and infants gut microbiota and break the obesity 
cycle. The use of prebiotics, probiotics and changes on maternal lifestyle may be successful 
interventions to avoid children dysbiosis and consequent obesity (Figure 2). 
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Figure 2. Gut microbiota development and risk of infant obesity. 
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CONCLUSIONS  
Despite the large amount of scientific publications, there is still much work to do regarding the 
clarification of mechanisms and the possible therapy for childhood obesity. 
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